rs199589074
Variant summary
Our verdict is Likely pathogenic. Variant got 6 ACMG points: 6P and 0B. PM1PM2PP3_Moderate
The NM_138694.4(PKHD1):c.6121G>A(p.Gly2041Ser) variant causes a missense, splice region change. The variant allele was found at a frequency of 0.0000423 in 1,606,010 control chromosomes in the GnomAD database, with no homozygous occurrence. 2/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_138694.4 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 6 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PKHD1 | ENST00000371117.8 | c.6121G>A | p.Gly2041Ser | missense_variant, splice_region_variant | Exon 37 of 67 | 1 | NM_138694.4 | ENSP00000360158.3 | ||
PKHD1 | ENST00000340994.4 | c.6121G>A | p.Gly2041Ser | missense_variant, splice_region_variant | Exon 37 of 61 | 5 | ENSP00000341097.4 |
Frequencies
GnomAD3 genomes AF: 0.000204 AC: 31AN: 152230Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000756 AC: 19AN: 251302Hom.: 0 AF XY: 0.0000589 AC XY: 8AN XY: 135802
GnomAD4 exome AF: 0.0000255 AC: 37AN: 1453662Hom.: 0 Cov.: 30 AF XY: 0.0000207 AC XY: 15AN XY: 723808
GnomAD4 genome AF: 0.000203 AC: 31AN: 152348Hom.: 0 Cov.: 33 AF XY: 0.000188 AC XY: 14AN XY: 74502
ClinVar
Submissions by phenotype
Autosomal recessive polycystic kidney disease Uncertain:3
This sequence change replaces glycine with serine at codon 2041 of the PKHD1 protein (p.Gly2041Ser). The glycine residue is moderately conserved and there is a small physicochemical difference between glycine and serine. This variant also falls at the last nucleotide of exon 37, which is part of the consensus splice site for this exon. This variant is present in population databases (rs199589074, ExAC 0.09%). This missense change has been observed in individual(s) with polycystic kidney disease (PMID: 27225849). ClinVar contains an entry for this variant (Variation ID: 549940). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). Variants that disrupt the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
- -
- -
not provided Uncertain:2
- -
Reported without a second variant in a patient with polycystic kidney disease (Melchionda et al., 2016); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 33940108, 27225849, 32256442) -
Polycystic kidney disease 4 Uncertain:2
- -
- -
not specified Uncertain:1
Variant summary: PKHD1 c.6121G>A (p.Gly2041Ser) results in a non-conservative amino acid change located in the G8 domain of the encoded protein sequence which affects the last nucleotide of exon 37. Five of five in-silico tools predict a damaging effect of the variant on protein function. Several computational tools predict a significant impact on normal splicing: Four predict the variant weakens a 5' donor site. Four predict the variant creates a 3' acceptor site. However, these predictions have yet to be confirmed by functional studies. The variant allele was found at a frequency of 7.6e-05 in 251302 control chromosomes. This frequency is not significantly higher than expected for a pathogenic variant in PKHD1 causing Polycystic Kidney And Hepatic Disease (7.6e-05 vs 0.0071), allowing no conclusion about variant significance. c.6121G>A has been reported in the literature in individuals affected with Polycystic Kidney And Hepatic Disease, without strong evidence for causality (Melchionda_2016, Burgamaier_2021). These reports do not provide unequivocal conclusions about association of the variant with Polycystic Kidney And Hepatic Disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. Three clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation. All laboratories classified the variant as uncertain significance. Based on the evidence outlined above, the variant was classified as uncertain significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at